Efficacy and Safety of PDM011011 Capsules as Compared to Metformin in Subjects with Type-2 Diabetes Mellitus: An Open-Label, Randomized, Active-Controlled, Multicentric, Phase III Study

Phase Iii ◽

Efficacy And Safety ◽

Open Label ◽

Phase Iii Study

Phase III Study on Efficacy and Safety of Triple Combination (Exenatide/Metformin/Biphasic Insulin Aspart) Therapy for Type 2 Diabetes Mellitus

American Journal of Therapeutics ◽

10.1097/mjt.0000000000000431 ◽

2018 ◽

Vol 25 (6) ◽

pp. e609-e616 ◽

Cited By ~ 1

Author(s):

Ke Su ◽

Chunmei Lv ◽

Zongwen Ji ◽

Yishu Wang ◽

Haifeng Wang ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Insulin Aspart ◽

Phase Iii ◽

Efficacy And Safety ◽

Triple Combination ◽

Biphasic Insulin ◽

Phase Iii Study

Efficacy and safety of LY2963016 insulin glargine versus insulin glargine (Lantus®) in Chinese adults with type 2 diabetes mellitus: A Phase III , randomised, open‐label, controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.14392 ◽

2021 ◽

Author(s):

Wenhuan Feng ◽

Wei Chen ◽

Shan Jiang ◽

Liying Du ◽

Dalong Zhu

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Phase Iii ◽

Efficacy And Safety ◽

Chinese Adults ◽

Open Label

Efficacy and safety of once-weekly dulaglutide versus insulin glargine in mainly Asian patients with type 2 diabetes mellitus on metformin and/or a sulphonylurea: A 52-week open-label, randomized phase III trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.13506 ◽

2018 ◽

Vol 21 (2) ◽

pp. 234-243 ◽

Cited By ~ 16

Author(s):

Weiqing Wang ◽

Luis Nevárez ◽

Ekaterina Filippova ◽

Ki Ho Song ◽

Bei Tao ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Insulin Glargine ◽

Phase Iii ◽

Efficacy And Safety ◽

Open Label ◽

Phase Iii Trial ◽

Asian Patients

Decision letter for "Efficacy and safety of insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi 1:1) in Japanese patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs: A randomized, 26-week, open-label, multicenter study: The L"

10.1111/dom.14036/v3/decision1 ◽

2020 ◽

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Fixed Ratio ◽

Japanese Patients ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Open Label ◽

Decision letter for "Efficacy and safety of insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi 1:1) in Japanese patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs: A randomized, 26-week, open-label, multicenter study: The L"

10.1111/dom.14036/v2/decision1 ◽

2020 ◽

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Fixed Ratio ◽

Japanese Patients ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Open Label ◽

Review for "Efficacy and safety of insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi 1:1) in Japanese patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs: A randomized, 26-week, open-label, multicenter study: The L"

10.1111/dom.14036/v1/review1 ◽

2019 ◽

Author(s):

Graydon Meneilly

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Fixed Ratio ◽

Japanese Patients ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Open Label ◽

Dapagliflozin as Monotherapy in Drug-Naive Asian Patients With Type 2 Diabetes Mellitus: A Randomized, Blinded, Prospective Phase III Study

Clinical Therapeutics ◽

10.1016/j.clinthera.2013.11.002 ◽

2014 ◽

Vol 36 (1) ◽

pp. 84-100.e9 ◽

Cited By ~ 89

Author(s):

Linong Ji ◽

Jianhua Ma ◽

Hongmei Li ◽

Traci A. Mansfield ◽

Caroline L. T’joen ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Phase Iii ◽

Asian Patients ◽

Prospective Phase ◽

Phase Iii Study ◽

Drug Naïve

A Prospective, Randomized, Open-Label Study Comparing the Efficacy and Safety of Preprandial and Prandial Insulin in Combination with Acarbose in Elderly, Insulin-Requiring Patients with Type 2 Diabetes Mellitus

Diabetes Technology & Therapeutics ◽

10.1089/dia.2012.0275 ◽

2013 ◽

Vol 15 (6) ◽

pp. 513-519 ◽

Cited By ~ 5

Author(s):

Guang Yang ◽

Chunlin Li ◽

Yanping Gong ◽

Jian Li ◽

Xiaoling Cheng ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Efficacy And Safety ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Prandial Insulin

Efficacy and safety of Glycebal (PDM011011) capsules as adjuvant therapy in subjects with type 2 diabetes mellitus: an open label, randomized, active controlled, phase II trial

Clinical Diabetology ◽

10.5603/dk.2016.0015 ◽

2016 ◽

Vol 5 (3) ◽

pp. 88-94 ◽

Cited By ~ 1

Author(s):

Ashish C. Suthar ◽

Anand Deshmukh ◽

Vijaya Babu ◽

Vijaya S. Mohan ◽

Madhukar V. Chavan ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Adjuvant Therapy ◽

Phase Ii ◽

Phase Ii Trial ◽

Efficacy And Safety ◽

Open Label

Author response for "Efficacy and safety of insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi 1:1) in Japanese patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs: A randomized, 26-week, open-label, multicenter study: The L"

10.1111/dom.14036/v3/response1 ◽

2020 ◽

Author(s):

Yasuo Terauchi ◽

Takahiro Nakama ◽

Robert Spranger ◽

Atsushi Amano ◽

Takahiro Inoue ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Fixed Ratio ◽

Japanese Patients ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Open Label ◽